Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918100 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
Whilst this is a relatively small retrospective study and lacks information on the distribution of active PBM, IMRT treatment has been shown to significantly increase PMB irradiation. PBM dose metrics have been shown to be predictive of WCC and ANC suppression. NTCP modeling predicts much high risk of HT3+. Paradoxically, actual rates of HT3+ were comparable suggesting that differences in the distributions of dose metrics maybe a significant factor and/or that there are insufficiency in the NTCP modeling.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Maxwell Robinson, Ahmed Sabbagh, Rebecca Muirhead, Lisa Durrant, Frank Van den Heuvel, Maria Hawkins,